Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.225 CAD | -11.76% | -16.67% | +18.42% |
05-29 | Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger | MT |
05-29 | Ceapro Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CEAPRO INC. | Other Biotechnology & Medical Research | -11.76% | -16.67% | +18.42% | -51.09% | -43.75% | 12.91M | - | - | - |
- Stock Market
- Equities
- CZO Stock
- Charts Ceapro Inc.
- Relative Strength Chart